Skip to main content
Year archive

Telix Pharmaceuticals Ltd — 2018 filings

All 76 regulatory filings released by Telix Pharmaceuticals Ltd (TLX) in 2018, sourced directly from the official regulator.

76 Filings
2018 Period
2018 filings (76)
Filing Released Lang
Telix Pharmaceuticals Completes Acquisition of ANMI SA 2 pages 205.8KB
M&A Activity
2018-12-23 English
Cleansing Notice - Issue of Consideration Shares 1
Share Issue/Capital Change
2018-12-23 English
Appendix 3B - Issue of Consideration Shares 13 pages 137.9KB
Capital/Financing Update
2018-12-23 English
Appointment of Nannette Rich to Lead US Sales & Marketing 3 pages 173.7KB
Board/Management Information
2018-12-20 English
TLX250 ZIR-DOSE Clinical Study Completes Enrolment 3 pages 87.8KB
Regulatory Filings
2018-12-18 English
Renal Cancer Imaging Program - Japanese Regulatory Update 3 pages 86.7KB
Regulatory Filings
2018-12-18 English
ANMI Investor Conference Call - link to audio recording 1
Regulatory Filings
2018-12-02 English
Nihon Medi-Physics Collaboration on Actinium Renal Cancer 2 pages 94.7KB
Regulatory Filings
2018-11-28 English
Atlab Acquisition - Voluntary Escrow Shares to be released 1
Capital/Financing Update
2018-11-26 English
Telix Acquires Advanced Nuclear Medicine Ingredients SA 3 pages 187.3KB
M&A Activity
2018-11-25 English
ANMI Transaction - Market Briefing 15 pages 2.0MB
M&A Activity
2018-11-25 English
ANMI Transaction - Investor Conference Call Details 2 pages 201.1KB
Call Transcript
2018-11-25 English
Appendix 4C - September Quarter 7 pages 556.0KB
Interim / Quarterly Report Q3 2018
2018-10-30 English
Quarterly Program Update 9 pages 1.4MB
Interim / Quarterly Report Q3 2018
2018-10-30 English
Telix Commences ZIRCON Phase III Renal Cancer Imaging Trial 2 pages 215.6KB
Regulatory Filings
2018-10-22 English
Telix Receives Approval to Commence Glioblastoma Trial 2 pages 167.2KB
Regulatory Filings
2018-10-17 English
RTM to Manufacture Kidney Imaging Program in Europe 2 pages 188.6KB
Regulatory Filings
2018-10-16 English
Seibersdorf Laboratories Appointed for Glioblastoma Program 2 pages 156.7KB
Regulatory Filings
2018-10-15 English
Cyclotek Manufacturing Partnership for Kidney Cancer Imaging 2 pages 188.6KB
Capital/Financing Update
2018-10-14 English
Telix and ANMI Expand PSMA Imaging Partnership 2 pages 195.0KB
Regulatory Filings
2018-10-14 English
Interim Analysis of ZIR-DOSE Study Shows Improved Dosimetry 2 pages 196.3KB
Regulatory Filings
2018-10-14 English
Strategic Collaboration Agreement with GenesisCare 2 pages 163.2KB
Regulatory Filings
2018-10-09 English
Illumet Commercial Update 15 pages 2.5MB
Investor Presentation
2018-10-03 English
Agreement with Cardinal Health for Prostate Cancer Imaging 2 pages 163.6KB
Regulatory Filings
2018-10-02 English
Atlab Investor Conference Call - link to audio recording 1
Call Transcript
2018-09-13 English
Appendix 3Y change of director's interests - Jann Skinner 2 pages 98.9KB
Director's Dealing
2018-09-13 English
Ceasing to be a substantial holder 2 pages 57.5KB
Major Shareholding Notification
2018-09-13 English
Telix completes acquisition of Atlab Pharma 3 pages 232.7KB
M&A Activity
2018-09-10 English
Atlab Transaction - Market Briefing 15 pages 2.7MB
Investor Presentation
2018-09-10 English
Atlab Transaction - Conference Call 2 pages 192.4KB
Regulatory Filings
2018-09-10 English
Section 708A(5)(e) Notice - Cleansing Notice 1 page
Capital/Financing Update
2018-09-10 English
Appendix 3B - issue of consideration shares and warrants 14 pages 142.3KB
Capital/Financing Update
2018-09-10 English
Trading Halt 2 pages 387.3KB
Regulatory Filings
2018-09-09 English
TLX receives ethics approval to commence Glioblastoma Study 2 pages 162.1KB
Regulatory Filings
2018-09-03 English
Half Yearly Report and Accounts 21 pages 10.0MB
Interim / Quarterly Report H1 2018
2018-08-30 English
Policy- Compassionate Use Access to Investigational Medicine 2 pages 185.5KB
Regulatory Filings
2018-08-30 English
Telix, U Melb and Peter Mac collaborate on colorectal cancer 3 pages 216.7KB
Regulatory Filings
2018-08-23 English
Telix files Ph III trial for Kidney Cancer Imaging in Europe 2 pages 166.7KB
Capital/Financing Update
2018-08-22 English
3B clarification unquoted securities subject to restriction 13 pages 108.1KB
Capital/Financing Update
2018-08-16 English
Collaboration on Renal Cancer Imaging for Japanese market 2 pages 213.3KB
Regulatory Filings
2018-08-15 English
Appendix 3B - lapse of unlisted share options 13 pages 138.2KB
Capital/Financing Update
2018-08-15 English
First Patient Imaged in Prostate Imaging Study 2 pages 219.7KB
Regulatory Filings
2018-08-12 English
Telix JV Entity Extends Contract with Endocyte to Include EU 1
Regulatory Filings
2018-08-09 English
Telix receives $55m Overseas Finding 2 pages 174.8KB
Capital/Financing Update
2018-08-02 English
TLX and JFE progress Japanese manufacturing partnership 2 pages 168.5KB
Capital/Financing Update
2018-07-25 English
Appendix 4C - June 2018 Quarter 7 pages 571.8KB
Interim / Quarterly Report Q2 2018
2018-07-25 English
Quarterly Program Update 9 pages 1.1MB
Interim / Quarterly Report Q2 2018
2018-07-25 English
Prostate imaging regulatory update - FDA review of DMF 2 pages 187.0KB
Regulatory Filings
2018-07-24 English
Telix and Isologic conclude manufacturing agreement 2 pages 183.4KB
Capital/Financing Update
2018-06-24 English
Appointment of Jann Skinner to the Board of Directors 1
Board/Management Information
2018-06-18 English
Appendix 3X - Jann Skinner 2 pages 83.3KB
Director's Dealing
2018-06-18 English
SEIF Grant Awarded for Advanced Biologics Manufacturing 2 pages 151.6KB
Regulatory Filings
2018-06-17 English
Appendix 3B - unlisted options under equity incentive plan 13 pages 134.2KB
Capital/Financing Update
2018-06-03 English
App 3B - options under equity incentive plan - correction 13 pages 134.5KB
Capital/Financing Update
2018-06-03 English
CEO presentation to Wilsons Rapid Insights Conference 22 pages 2.4MB
Investor Presentation
2018-05-30 English
Telix and Osaka U receive funding for Alpha Nuclide Research 2 pages 173.4KB
Regulatory Filings
2018-05-29 English
Appendix 4C - March 2018 quarter 6 pages 526.7KB
Interim / Quarterly Report Q1 2018
2018-04-26 English
Chairman and CEO Address to Shareholders 3 pages 473.0KB
AGM Information
2018-04-18 English
AGM - Results of Meeting 2 pages 208.5KB
Declaration of Voting Results & Voting Rights Announcements
2018-04-18 English
Translational Research Partnership with INSERM and ARRONAX 3 pages 169.2KB
Regulatory Filings
2018-04-15 English
Telix JV Entity Contract with Endocyte for Prostate Imaging 1
Regulatory Filings
2018-04-09 English
Update - prostate imaging program 15 pages 1.7MB
Investor Presentation
2018-03-27 English
Drug Master File for Prostate Imaging Product Filed with FDA 2 pages 220.3KB
Regulatory Filings
2018-03-25 English
Telix and Radboud University Medical Centre Collaboration 2 pages 168.6KB
Regulatory Filings
2018-03-14 English
AGM Notice of Meeting and Proxy Form 17 pages 565.7KB
AGM Information
2018-03-14 English
Appendix 3B - release of shares from mandatory escrow 13 pages 126.8KB
Capital/Financing Update
2018-03-05 English
Odile Jaume to lead Telix European Operations 1 pag
Board/Management Information
2018-02-28 English
Appendix 4E and 2017 Annual Report 58 pages 2.3MB
Annual Report FY 2017
2018-02-25 English
Appendix 4G - key to governance disclosures 11 pages 215.1KB
Governance Information
2018-02-25 English
Corporate Governance Statement 9 pages 262.8KB
Governance Information
2018-02-25 English
Shareholder Update 23 pages 2.2MB
Investor Presentation
2018-02-20 English
Notification regarding release of restricted securities 2 pages 156.3KB
Capital/Financing Update
2018-02-08 English
Appendix 4C - December 2017 quarter 6 pages 571.1KB
Interim / Quarterly Report Q4 2017
2018-01-29 English
App 3B - shares released from ASX mandatory escrow 13 pages 140.4KB
Capital/Financing Update
2018-01-14 English
Summary of voluntary escrow arrangements 1 page 157
Capital/Financing Update
2018-01-14 English
Telix establishes Japanese subsidiary 2 pages 327.2KB
Board/Management Information
2018-01-14 English